News

Deal Announcements

Avila Therapeutics Nets $30 Million Series B Funding

Wednesday, July 29, 2009 5:36:00 AM PDT | VentureDeal Staff
Waltham, Massachusetts  --  Biotechnology company Avila Therapeutics has raised $30 million in its second round of institutional venture capital financing.

Avila says that it is "focused on the discovery and development of novel small molecule therapeutics."

Novartis Venture Fund led the round, which also included Abingworth Management, Advent Venture Partners, Atlas Venture and Polaris Venture Partners. The company said that the funding proceeds would be used to move its first program into clinical trials.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1